SCHEMBL640127

SCHEMBL640127

NC(O)c1ccccc1O

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GABRA1 P14867 1/20 0.54
GABRB2 P47870 1/20 0.54
TSHR P16473 3/20 0.48
ALDH1A1 P00352 4/20 0.45
ALOX15 P16050 3/20 0.45
HPGD P15428 3/20 0.45
HSD17B10 Q99714 3/20 0.45
KDM4E B2RXH2 3/20 0.45
MAPT P10636 3/20 0.45
CA2 P00918 3/20 0.45
LMNA P02545 3/20 0.45
POLB P06746 2/20 0.45
EGFR P00533 2/20 0.45
FYN P06241 2/20 0.45
MMP9 P14780 2/20 0.45
RECQL P46063 2/20 0.45
TDP1 Q9NUW8 2/20 0.45
NPC1 O15118 2/20 0.45
CA4 P22748 2/20 0.45
SMN1; SMN2 Q16637 2/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Bromide SCHEMBL209321 0.97 GABRA1 (0.52) GABRA1GABRB2TSHRALDH1A1ALOX15
Phosphoric Acid SCHEMBL15110087 0.89 GABRA1 (0.45) GABRA1GABRB2TSHRALDH1A1ALOX15
SCHEMBL6765024 0.83 LMNA (0.40) GABRA1GABRB2TSHRALDH1A1HPGD
SCHEMBL18650079 0.81 GABRA1 (0.56) GABRA1GABRB2TSHRALDH1A1ALOX15
SCHEMBL4681487 0.81 GABRA1 (0.56) GABRA1GABRB2TSHRALDH1A1ALOX15
SCHEMBL25415814 0.81 GABRA1 (0.56) GABRA1GABRB2TSHRALDH1A1ALOX15
SCHEMBL3949185 0.81 GABRA1 (0.56) GABRA1GABRB2TSHRALDH1A1ALOX15
SCHEMBL15670229 0.81 GABRA1 (0.56) GABRA1GABRB2TSHRALDH1A1ALOX15
SCHEMBL29395043 0.81 GABRA1 (0.56) GABRA1GABRB2TSHRALDH1A1ALOX15
SCHEMBL3833921 0.81 GABRA1 (0.56) GABRA1GABRB2TSHRALDH1A1ALOX15

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 197 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2017210262-A1 PREVENTION AND TREATMENT OF VIRAL INFECTIONS BARANOWITZ STEVEN (US) 2017-12-07 WO claimed
US-20120149849-A1 MULTI-ARMED CATECHOL COMPOUND BLENDS KNC NER ACQUISITION SUB, INC. (US) 2012-06-14 US claimed
EP-2348835-A1 MULTI-ARMED CATECHOL COMPOUND BLENDS KNC NER Acquisition Sub, Inc. (US) 2011-08-03 EP claimed
EP-1475094-B1 Pyrazolo[4,3-D]pyrimidines, process for their preparation and methods of use USTAV EX BOTAN AKADEMIE VED CE (CZ) 2010-07-28 EP claimed
US-20100113828-A1 MULTI-ARMED CATECHOL COMPOUND BLENDS NERITES CORPORATION (US) 2010-05-06 US claimed
WO-2010037045-A1 MULTI-ARMED CATECHOL COMPOUND BLENDS NERITES CORPORATION (US) 2010-04-01 WO claimed
US-20070167466-A1 \"Pyrazolo [4,3-d]pyrimidines, processes for their preparation and methods of use\ UNIVERZITA PALACKEHO V OLOMOUCI (CZ) 2007-07-19 US claimed
WO-2004098608-A1 PYRAZOLO [4, 3-D]PYRIMIDINES, PROCESSES FOR THEIR PREPARATION AND METHODS OF USE ÚSTAV EXPERIMENTALNI BOTANIKY AKADEMIE VED CESKE REPUBLIKY (CZ) 2004-11-18 WO claimed
EP-1475094-A1 Pyrazolo[4,3-D]pyrimidines, process for their preparation and methods of use Ustav Experimentalni Botaniky Akademie ved Ceské Republiky (CZ) 2004-11-10 EP claimed
EP-0311385-B1 OPTICALLY ACTIVE HYDROXYBENZYLAMINE DERIVATIVE, OPTICALLY ACTIVE AMINE-BORON COMPOUND CONTAINING SAID DERIVATIVE, AND PROCESS FOR PRODUCING OPTICALLY ACTIVE COMPOUND BY USING SAID COMPOUND SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 1993-02-03 EP claimed
EP-0091385-A1 Process for the preparation of p-hydroxybenzyl nitriles or p-hydroxybenzyl amines RHONE-POULENC SPECIALITES CHIMIQUES (FR) 1983-10-12 EP claimed
US-20240238297-A1 USES AND METHODS FOR RECURRENT PRIMARY CNS NEOPLASMS CHIMERIX, INC. 2024-07-18 US disclosed
CN-117903072-A Dopa compound and preparation method and application thereof 深圳市松柏科工股份有限公司 2024-04-19 CN disclosed
CN-112980595-B Recyclable multifunctional nano surfactant and preparation method thereof 中国科学院生态环境研究中心 2022-03-18 CN disclosed
EP-3941990-A1 FUNCTIONAL GRAPHENIC MATERIALS FOR USE AS ADHESIVES AND SEALANTS Carnegie Mellon University (US) 2022-01-26 EP disclosed
EP-0091385-B1 PROCESS FOR THE PREPARATION OF P-HYDROXYBENZYL NITRILES OR P-HYDROXYBENZYL AMINES RHONE-POULENC SPECIALITES CHIMIQUES (FR) 1985-06-12 EP disclosed
US-4511659-A Liquid chromatograph with electrochemical detector and method ESA, INC. (US) 1985-04-16 US disclosed
EP-0122009-A2 Electrochemical detection system ESA, Inc. (US) 1984-10-17 EP disclosed
EP-0091385-A1 Process for the preparation of p-hydroxybenzyl nitriles or p-hydroxybenzyl amines RHONE-POULENC SPECIALITES CHIMIQUES (FR) 1983-10-12 EP disclosed
US-3968104-A SOLVENTS BAYER AKTIENGESELLSCHAFT (DT) 1976-07-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100113828-A1 MULTI-ARMED CATECHOL COMPOUND BLENDS COMT, HAAO, PNMT GABRA1 3745/4885GABRB2 3544/4885TSHR 4861/4885
US-20070167466-A1 \"Pyrazolo [4,3-d]pyrimidines, processes for their preparation and methods of use\ CBR3, PYM1, PNPO GABRA1 1525/4885GABRB2 1950/4885TSHR 893/4885
US-20240238297-A1 USES AND METHODS FOR RECURRENT PRIMARY CNS NEOPLASMS MKI67, BCL6, CBX6 GABRA1 3634/4885GABRB2 3444/4885TSHR 2417/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.